Selling by month
Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.
Disclosed planOne dollar scale for every month; the tallest bar is labeled
Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 12 of the 13 calendar months from Oct 2025 to Oct 2026: Oct 2025, Nov 2025, Dec 2025, Jan 2026, Feb 2026, Mar 2026, Apr 2026, Jun 2026, Jul 2026, Aug 2026, Sep 2026 and Oct 2026.
- Largest single sale: $17.3M (115,640 shares) of Gilead Sciences on Feb 5, 2026. Filing
- Last sale before this period: Sep 29, 2025.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| Gilead Sciences (GILD) | Chairman & CEO, Director | Mar 5, 2019 | Oct 2, 2026 |
Recent filings
The last 5 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- Oct 1, 2026, Gilead Sciences: sold 15,000 shares for $2.2M, under a disclosed plan. 1 filing: 1
- Sep 10, 2026, Gilead Sciences: 8,780 shares vested; 4,230 shares withheld by the company for taxes. 1 filing: 1
- Sep 1, 2026, Gilead Sciences: sold 15,000 shares for $2.2M, under a disclosed plan. 1 filing: 1
- Aug 3, 2026, Gilead Sciences: sold 15,000 shares for $2.0M, under a disclosed plan. 1 filing: 1
- Jul 1, 2026, Gilead Sciences: sold 15,000 shares for $1.9M, under a disclosed plan. 1 filing: 1
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.